AstraZeneca to buy French biotechnology firm Amolyt Pharma for $1B
Acquisition to enable late-stage rare disease pipeline to develop to address medical needs of rare hormone deficiency
Source link
Acquisition to enable late-stage rare disease pipeline to develop to address medical needs of rare hormone deficiency
Source link
